- Report
- August 2024
- 135 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 147 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2024
- 128 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 135 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 139 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 130 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 140 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Clinical Trials
- December 2024
- 240 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- September 2024
- 132 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- August 2024
- 233 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- May 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more